News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,612 Results
Type
Article (14907)
Company Profile (299)
Press Release (266400)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79840)
Career Advice (162)
Deals (13339)
Drug Delivery (39)
Drug Development (50700)
Employer Resources (33)
FDA (5837)
Job Trends (5168)
News (145084)
Policy (10074)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21763)
ALS (125)
Alzheimer's disease (1031)
Antibody-drug conjugate (ADC) (241)
Approvals (6032)
Artificial intelligence (259)
Autoimmune disease (111)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3130)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43671)
Collaboration (1148)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1100)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4321)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1379)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (31643)
Editorial (26)
Employer branding (4)
Employer resources (31)
Events (51664)
Executive appointments (621)
FDA (7589)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (504)
Government (1147)
Grass and pollen (3)
Guidances (166)
Healthcare (6611)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1204)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7346)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (23)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (249)
Machine learning (24)
Management (9)
Manufacturing (376)
MASH (130)
Medical device (2662)
Medtech (2671)
Mergers & acquisitions (6617)
Metabolic disorders (724)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1953)
Neurotech (1)
NextGen: Class of 2026 (2035)
Non-profit (866)
Now hiring (30)
Obesity (329)
Opinion (126)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (329)
Peanut (43)
People (26652)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15475)
Phase 2 (20289)
Phase 3 (12822)
Pipeline (3252)
Policy (91)
Postmarket research (853)
Preclinical (6536)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (648)
Real estate (1448)
Recruiting (13)
Regulatory (9899)
Reports (19)
Research institute (971)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (25)
Last 7 days (340)
Last 30 days (1139)
Last 365 days (17823)
2026 (1676)
2025 (18100)
2024 (20544)
2023 (22415)
2022 (26823)
2021 (27805)
2020 (23357)
2019 (16225)
2018 (11739)
2017 (13746)
2016 (11841)
2015 (14351)
2014 (10395)
2013 (7486)
2012 (7532)
2011 (7615)
2010 (7429)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18252)
Australia (3111)
California (7077)
Canada (1837)
China (773)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39160)
Florida (903)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (160)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5585)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1646)
New Mexico (13)
New York (1762)
North Carolina (827)
North Dakota (6)
Northern California (3475)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2808)
Tennessee (40)
Texas (906)
United States (23337)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
281,612 Results for "pendulum therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pendulum Therapeutics Appoints Former Starbucks CEO Laxman Narasimhan to Board of Directors
October 7, 2025
·
4 min read
Drug Development
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.
February 24, 2025
·
6 min read
·
Christian Antoni
Business
Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer
Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.
January 9, 2024
·
5 min read
Biotech Bay
Halle Berry, Long-Standing Pendulum Customer, Joins Company as Chief Communications Officer, and Becomes Equity Owner and Investor
Pendulum Therapeutics announced that Halle Berry, Academy Award® winning actress and director, has joined the company as equity owner, investor and Chief Communications Officer.
February 9, 2023
·
4 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Biotech Bay
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila, a Key Strain Forging a Path for the Future of Probiotics
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila , a Key Strain Forging a Path for the Future of Probiotics.
June 10, 2022
·
2 min read
Biotech Bay
Pendulum Therapeutics Provides Leadership in Microbiome Education among Healthcare Professionals
Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the microbiome and its relationship to metabolic disease, including type 2 diabetes.
October 28, 2021
·
3 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
Biotech Bay
Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes
Pendulum Therapeutics , a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced today the launch of Pendulum Glucose Control, the first and only medical probioti
June 4, 2020
·
5 min read
1 of 28,162
Next
